Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Slowing Down Stock
1050.4000 9.40 (0.90%)
NSE Aug 22, 2025 15:31 PM
Volume: 1.9M
 

1050.40
0.90%
Geojit BNP Paribas
with multiple regulatory milestones lined up in the coming quarters. Execution of the pipeline delivery and expansion initiatives is expected to support long-term value creation. Therefore, we maintain our rating on the stock at BUY, with rolledforward target price of Rs. 1,348, based on 17.5x FY27x Adj. EPS....
Aurobindo Pharma Ltd. is trading below all available SMAs
More from Aurobindo Pharma Ltd.
Recommended